The book gives an insight into the thorough study and examination of incumbent biosystems, their present status and disruption in their integrity, causes and effects, measures to be taken for their characterization and restoration apart from advances and applications in the field of biosciences, drug design, discovery, bio-systems, biomedical and drug delivery technologies, tools in particular. The book collates information from several disciplines, such as chemistry, biology, material science, engineering, statistics, biomedicine, genetics, etc., as the subject in question is a confluence of many disciplines exhibiting numerous applications such as bioimaging, novel biological agents, synthesis, discovery testing, characterization of drugs right from selecting a suitable precursor to discovering and designing a drug following a correct synthetic route, adoption of computer simulation-based models, AI/ML-based models, application of statistical tools in analyzing and interpreting data, design, multi-functional, and operational drug delivery systems, their bio-compatibility, capacity of carrying and release of drug reproducibly etc.
The book is helpful to postgraduate students, research scholars, academicians, and scientists from the pharmaceutical, biotechnology, and chemical engineering domains. The book covers a conceptual understanding of the exploration of drugs in unity with the applications desired, sound bio-system development, and carriers for drug and supplement delivery.
Innehållsförteckning
1. Editorial: Future of Novel Technologies in Biosystems, Biomedicine, and Drug Delivery.- Part I; Novel Technologies in Biosystems, Biomedicine, and Drug Delivery: Characterization.- 2. Characterization Tools for Current Drug Delivery Systems.- 3. Characterization of Transdermal Drug Delivery Systems: Retrospect and Future Prospects.- 4. Analytical Tools for the Characterization of Nasal Spray Drug Products.- Part II: Novel Technologies in Biosystems, Biomedicine, and Drug Delivery: Restoration.- 5. AI-Enabled Models in the Restoration of Drug Efficacy and Drug Design.- 6. Restoration and Sustenance of Nano drug delivery systems: potential, Challenges, and limitations.- 7. Artificial Intelligence and Machine Learning in Restoring and Strengthening Health Care.- Part III: Novel Technologies in Biosystems, Biomedicine, and Drug Delivery: Optimization.- 8. Optimizing Oncology Tools: Organ-on-a-clip alternative to animal model.- 9. Optimizing Drug Synthesis: AI-Powered Kinetics study in Pharmaceutical Research.- 10. In Silico Toxicological Protocols Optimization for the Prediction of Toxicity of Drugs.- 11. Optimizing Healthcare Throughput: The Role of Machine Learning and Data Analytics.- Part IV: Novel Technologies in Biosystems, Biomedicine, and Drug Delivery: Applications.- 12. Applications of AI-based Models in the field of Biomedicine.- 13. Application of New Biological Entities (NBEs) as Therapeutics.- 14. Applications of Computational Tools in the Prediction of Toxicity.- 15. Application of Peptides for the treatment of diabetes: A plant-based bioactive material.- 16. Regenerative Medicines: Application to Degenerative Diseases and Disorders.
Om författaren
Shrikaant Kulkarni, Ph.D., is currently a Research and Technical Advisor at Filantrofia Sarvada Clean Tech Pvt. Ltd., Pune, India, and Adjunct Professor at Padm. Dr. V. B. Kolte College of Engineering, Malkapur, India. He has published over 100+ research papers in national and international journals and conferences of repute. He has authored 50 book chapters and edited 20 books published by Apple Academic Press/CRC Press and Springer Nature. Another ten books are in the offing. He authored four textbooks in engineering chemistry. Dr Kulkarni possesses MSc, MPhil, and Ph D degrees in Chemistry and master’s degrees in Economics, Business Management, and Political Science. He has expertise in the fields of green chemistry and engineering, analytical chemistry, green nanoscience and nanotechnology, wastewater treatment, Green and Analytical Chemistry, and advanced areas in Chemical Engineering and Material Science, and Industrial Organization & Management.
A. K. Haghi, Ph.D., is a retired professor and has written, co-written, edited or co-edited more than 1000 publications, including books, book chapters, and papers in refereed journals with over 3700 citations and an h-index of 32, according to Google Scholar database. He is currently a senior material engineering consultant in the UK. Professor Haghi has received several grants, consulted for several major corporations, and is a frequent speaker to national and international audiences. He is the Founder and former Editor-in-Chief of the International Journal of Chemoinformatics and Chemical Engineering and Polymers Research Journal. Professor Haghi has acted as an editorial board member of many international journals. He has served as a member of the Canadian Research and Development Center of Sciences & Cultures and the Research Chemistry Centre, Coimbra, Portugal. He has supervised several Ph D and MSc theses at the University of Guilan (UG) and co-supervised international doctoral projects. Professor Haghi holds a BSc in urban and environmental engineering from the University of North Carolina (USA) and holds two MSc, one in mechanical engineering from North Carolina State University (USA) and another one in applied mechanics, acoustics, and materials from the Université de Technologie de Compiègne (France). He was awarded a Ph D in engineering sciences at Université de Franche-Comté (France). He is a persistent reviewer of leading international journals.
Ms. Sonali Manwatkar, Ph.D. (Pursuing), is an assistant professor in the School of Pharmacy, Pharmacology Department, Vishwakarma University. Ms. Manwatkar has delivered invited lectures and conducted sessions at national and international conferences and faculty development programs. She has worked as a research scientist in the drug metabolism and pharmacokinetics department of drug discovery & development at Glenmark Research Center, Mahape, Navi Mumbai. She teaches human anatomy, physiology, and pharmacology. She has been exposed to new drug discovery and developmental phases, research publications, and book chapters. She has expertise in in vivo and in vitro drug metabolism, pharmacokinetics, and bioanalysis.